[1]
|
NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 18-24.
PubMed=3360803 [NCBI, ExPASy, EBI, Israel, Japan]
Saus J.,
Quinones S.,
Otani Y.,
Nagase H.,
Harris E.D. Jr.,
Kurkinen M.;
"The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin.";
J. Biol. Chem. 263:6742-6745(1988).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Fibroblast;
PubMed=3030290 [NCBI, ExPASy, EBI, Israel, Japan]
Whitham S.E.,
Murphy G.,
Angel P.,
Rahmsdorf H.J.,
Smith B.,
Lyons A.,
Harris T.J.R.,
Reynolds J.J.,
Herrlich P.,
Docherty A.J.P.;
"Comparison of human stromelysin and collagenase by cloning and sequence analysis.";
Biochem. J. 240:913-916(1986).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=3477804 [NCBI, ExPASy, EBI, Israel, Japan]
Wilhelm S.M.,
Collier I.E.,
Kronberger A.,
Eisen A.Z.,
Marmer B.L.,
Grant G.A.,
Bauer E.A.,
Goldberg G.I.;
"Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells.";
Proc. Natl. Acad. Sci. U.S.A. 84:6725-6729(1987).
|
[4]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
Lin D.,
Duncan M.,
Allen E.,
Araujo R.,
Aparicio A.,
Chai A.,
Chung E.,
Davis K.,
Federspiel N.,
Hyman R.,
Kalman S.,
Komp C.,
Kurdi O.,
Lashkari D.,
Lew H.,
Namath A.,
Oefner P.,
Roberts D.,
Heller R.,
Davis R.W.;
"Three matrix metalloproteinases on 81kb of P1 insert.";
Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-45.
TISSUE=Synovium;
Suzuki Y.,
Sugano S.,
Totoki Y.,
Toyoda A.,
Takeda T.,
Sakaki Y.,
Tanaka A.,
Yokoyama S.;
Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLU-45.
SeattleSNPs program for genomic applications;
Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
|
[7]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-45.
TISSUE=Lung;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[8]
|
ZYMOGEN ACTIVATION.
DOI=10.1021/bi00476a020; PubMed=2383557 [NCBI, ExPASy, EBI, Israel, Japan]
Nagase H.,
Enghild J.J.,
Suzuki K.,
Salvesen G.;
"Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate.";
Biochemistry 29:5783-5789(1990).
|
[9]
|
STRUCTURE BY NMR OF CATALYTIC DOMAIN.
DOI=10.1038/nsb0294-111; PubMed=7656014 [NCBI, ExPASy, EBI, Israel, Japan]
Gooley P.R.,
O'Connell J.F.,
Marcy A.I.,
Cuca G.C.,
Salowe S.P.,
Bush B.L.,
Hermes J.D.,
Esser C.K.,
Hagmann W.K.,
Springer J.P.,
Johnson B.A.;
"The NMR structure of the inhibited catalytic domain of human stromelysin-1.";
Nat. Struct. Biol. 1:111-118(1994).
|
[10]
|
STRUCTURE BY NMR OF 100-267.
PubMed=9827994 [NCBI, ExPASy, EBI, Israel, Japan]
Stockman B.J.,
Waldon D.J.,
Gates J.A.,
Scahill T.A.,
Kloosterman D.A.,
Mizsak S.A.,
Jacobsen E.J.,
Belonga K.L.,
Mitchell M.A.,
Mao B.,
Petke J.D.,
Goodman L.,
Powers E.A.,
Ledbetter S.R.,
Kaytes P.S.,
Vogeli G.,
Marshall V.P.,
Petzold G.L.,
Poorman R.A.;
"Solution structures of stromelysin complexed to thiadiazole inhibitors.";
Protein Sci. 7:2281-2286(1998).
|
[11]
|
X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 18-272.
PubMed=8535233 [NCBI, ExPASy, EBI, Israel, Japan]
Becker J.W.,
Marcy A.I.,
Rokosz L.L.,
Axel M.G.,
Burbaum J.J.,
Fitzgerald P.M.D.,
Cameron P.M.,
Esser C.K.,
Hagmann W.K.,
Hermes J.D.,
Springer J.P.;
"Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.";
Protein Sci. 4:1966-1976(1995).
|
[12]
|
X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 100-266.
DOI=10.1016/S0969-2126(96)00043-3; PubMed=8740360 [NCBI, ExPASy, EBI, Israel, Japan]
Dhanaraj V.,
Ye Q.-Z.,
Johnson L.L.,
Hupe D.J.,
Otwine D.F.,
Dunbar J.B. Jr.,
Rubin J.R.,
Pavlovsky A.,
Humblet C.,
Blundell T.L.;
"X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily.";
Structure 4:375-386(1996).
|
[13]
|
X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 105-264.
DOI=10.1021/jm960465t; PubMed=9083493 [NCBI, ExPASy, EBI, Israel, Japan]
Esser C.K.,
Bugianesi R.L.,
Caldwell C.G.,
Chapman K.T.,
Durette P.L.,
Girotra N.N.,
Kopka I.E.,
Lanza T.J.,
Levorse D.A.,
Maccoss M.,
Owens K.A.,
Ponpipom M.M.,
Simeone J.P.,
Harrison R.K.,
Niedzwiecki L.,
Becker J.W.,
Marcy A.I.,
Axel M.G.,
Christen A.J., ![]()
McDonnell J.,
Moore V.L.,
Olszewski J.M.,
Saphos C.,
Visco D.M.,
Shen F.,
Colletti A.,
Kriter P.A.,
Hagmann W.K.;
"Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.";
J. Med. Chem. 40:1026-1040(1997).
|
[14]
|
X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 100-267 IN COMPLEX WITH TIMP1.
DOI=10.1038/37995; PubMed=9288970 [NCBI, ExPASy, EBI, Israel, Japan]
Gomis-Rueth F.-X.,
Maskos K.,
Betz M.,
Bergner A.,
Huber R.,
Suzuki K.,
Yoshida N.,
Nagase H.,
Brew K.,
Bourenkov G.P.,
Bartunik H.,
Bode W.;
"Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.";
Nature 389:77-81(1997).
|
[15]
|
X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 100-264.
PubMed=9792098 [NCBI, ExPASy, EBI, Israel, Japan]
Finzel B.C.,
Baldwin E.T.,
Bryant G.L. Jr.,
Hess G.F.,
Wilks J.W.,
Trepod C.M.,
Mott J.E.,
Marshall V.P.,
Petzold G.L.,
Poorman R.A.,
O'Sullivan T.J.,
Schostarez H.J.,
Mitchell M.A.;
"Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.";
Protein Sci. 7:2118-2126(1998).
|
[16]
|
X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 100-272.
DOI=10.1006/jmbi.1999.3147; PubMed=10543949 [NCBI, ExPASy, EBI, Israel, Japan]
Chen L.,
Rydel T.J.,
Gu F.,
Dunaway C.M.,
Pikul S.,
Dunham K.M.,
Barnett B.L.;
"Crystal structure of the stromelysin catalytic domain at 2.0-A resolution: inhibitor-induced conformational changes.";
J. Mol. Biol. 293:545-557(1999).
|
[17]
|
X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 100-267.
PubMed=10422833 [NCBI, ExPASy, EBI, Israel, Japan]
Pavlovsky A.G.,
Williams M.G.,
Ye Q.-Z.,
Ortwine D.F.,
Purchase C.F. II,
White A.D.,
Dhanaraj V.,
Roth B.D.,
Johnson L.L.,
Hupe D.,
Humblet C.,
Blundell T.L.;
"X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.";
Protein Sci. 8:1455-1462(1999).
|
[18]
|
STRUCTURE BY NMR OF 100-272.
DOI=10.1021/bi981328w; PubMed=9760240 [NCBI, ExPASy, EBI, Israel, Japan]
Li Y.C.,
Zhang X.,
Melton R.,
Ganu V.,
Gonnella N.C.;
"Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor.";
Biochemistry 37:14048-14056(1998).
|
|
ExPASy Home page
SIB Switzerland
